Looks like PhRMA is getting cold feet and threatening to blow up the deal it has with the White House on supporting health care reform. From the AP:
The drug industry is threatening to end its support for President Barack Obama’s health overhaul effort because of a rift with the administration over protecting brand-name biotech drugs from low-cost generic competitors.
In an e-mail obtained Friday by The Associated Press, the president of the Pharmaceutical Research and Manufacturers of America told the trade group’s board members that “we could not support the bill” if the industry is given less than 12 years of competitive protection for the expensive products. …
“Please activate immediately all of your contacts,” said the e-mail from Billy Tauzin, the group’s president.
David Kurtz is Managing Editor and Washington Bureau Chief of Talking Points Memo where he oversees the news operations of TPM and its sister sites.